In patients with renal cell carcinoma, IFIT5 expression is significantly higher in primary tumor tissue compared to benign tissues, and elevated levels of IFIT5 mRNA is a predictor of poor overall survival in patients [99]. The gene discussed is IFIT5; the disease is neoplasm.